Trials / Completed
CompletedNCT02815709
Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy
A Phase 3, Multicenter, Randomized, Double-blind, Placebo and Active-controlled Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 418 (actual)
- Sponsor
- Trevena Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The primary objective is to evaluate the analgesic efficacy of intravenous (IV) oliceridine administered as needed (PRN) compared with placebo in patients with moderate to severe acute postoperative pain after bunionectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oliceridine | |
| DRUG | Placebo | |
| DRUG | Morphine |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2016-12-01
- Completion
- 2017-01-01
- First posted
- 2016-06-28
- Last updated
- 2020-09-25
- Results posted
- 2020-09-25
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02815709. Inclusion in this directory is not an endorsement.